Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Medicine Corp. Grew Again in 2008

publication date: Mar 26, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Medicine Corporation announced that 2008 revenues increased 27% to $53.6 million, while net income actually outpaced the growth in revenues, rising 33% to $9.1 million. That is equivalent to 60 cents per share, fully diluted. The improved results build on a 75% increase in revenues in 2007. These results beat the company’s guidance, even though China Medicine warned in October 2008 it would not meet its forecast. At the time, China Medicine did not issue a lower set of numbers. More details...

Stock Symbol: (OTCBB: CHME)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...